These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30151654)

  • 1. Correction to: Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease.
    Willis MD; Robertson NP
    J Neurol; 2018 Oct; 265(10):2469. PubMed ID: 30151654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: EPAC Negatively Regulates Myelination via Controlling Proliferation of Oligodendrocyte Precursor Cells.
    Gao ZZ; Li YC; Shao CY; Xiao J; Shen Y; Zhou L
    Neurosci Bull; 2020 Jun; 36(6):682. PubMed ID: 32377989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
    Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S
    Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.
    Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G
    Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
    Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets.
    Dyer CA; Matthieu JM
    J Neurochem; 1994 Feb; 62(2):777-87. PubMed ID: 7507516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
    Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
    Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
    Dyer CA
    Mol Neurobiol; 1993; 7(1):1-22. PubMed ID: 8391270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extended optic neuropathy with myelin oligodendrocyte glycoprotein antibodies].
    Gillard F; Andris C; Lommers E
    Rev Med Liege; 2019 Apr; 74(4):179-184. PubMed ID: 30997966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
    Scolding NJ; Frith S; Linington C; Morgan BP; Campbell AK; Compston DA
    J Neuroimmunol; 1989 May; 22(3):169-76. PubMed ID: 2649509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Honegger P; Lassmann H; Matthieu JM
    J Neurochem; 1990 Aug; 55(2):583-7. PubMed ID: 1695240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
    Cobo-Calvo A; Sepúlveda M; d'Indy H; Armangué T; Ruiz A; Maillart E; Papeix C; Audoin B; Zephir H; Biotti D; Ciron J; Durand-Dubief F; Collongues N; Ayrignac X; Labauge P; Thouvenot E; Montcuquet A; Deschamps R; Solà-Valls N; Llufriu S; Blanco Y; de Seze J; Vukusic S; Saiz A; Marignier R; ;
    J Neurol; 2019 Apr; 266(4):816. PubMed ID: 30759286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction to: Characteristics of single ocular motor nerve palsy associated with anti-GQ1b antibody.
    Choi KD; Choi SY; Choi JH; Kim SH; Lee SH; Jeong SH; Kim HJ; Choi JY; Kim JS
    J Neurol; 2019 Feb; 266(2):480. PubMed ID: 30610429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
    Wei SH; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic linkage analysis of the antibody responses to myelin basic protein and myelin oligodendrocyte glycoprotein in rats immunized with rat spinal cord homogenate.
    Yang HT; Bergsteinsdottir K; Wernhoff P; Linington C; Pettersson U; Holmdahl R
    J Neuroimmunol; 2001 Jul; 117(1-2):21-9. PubMed ID: 11431001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin-associated glycoprotein, a member of the L2/HNK-1 family of neural cell adhesion molecules, is involved in neuron-oligodendrocyte and oligodendrocyte-oligodendrocyte interaction.
    Poltorak M; Sadoul R; Keilhauer G; Landa C; Fahrig T; Schachner M
    J Cell Biol; 1987 Oct; 105(4):1893-9. PubMed ID: 2444603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
    Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.